[HTML][HTML] ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious …
…, JT Silva, E Benamu, LH Calabrese, A Dumusc… - Clinical Microbiology …, 2018 - Elsevier
Background The present review is part of the ESCMID Study Group for Infections in
Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological …
Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological …
The role of IL-1 in gout: from bench to bedside
A So, A Dumusc, S Nasi - Rheumatology, 2018 - academic.oup.com
The translation of our knowledge of the biology of MSU crystal-induced IL-1 secretion gives
rise to new targets and therapeutic strategies in the treatment of acute gout. The NACHT, …
rise to new targets and therapeutic strategies in the treatment of acute gout. The NACHT, …
Interleukin-1 as a therapeutic target in gout
A Dumusc, A So - Current opinion in rheumatology, 2015 - journals.lww.com
There is sufficient evidence supporting the use of IL-1 blockers for treatment of acute gouty
arthritis or for prevention of gout flares when starting ULT in selected patients, with …
arthritis or for prevention of gout flares when starting ULT in selected patients, with …
Ultrasound can be useful to predict an evolution towards rheumatoid arthritis in patients with inflammatory polyarthralgia without anticitrullinated antibodies
P Zufferey, C Rebell, C Benaim, HR Ziswiler, A Dumusc… - Joint Bone Spine, 2017 - Elsevier
Introduction Ultrasound (US) subclinical synovitis in prerheumatoid arthritis (RA) patients has
been demonstrated in anticitrullinated antibodies (ACPA) positive patients to be predictive …
been demonstrated in anticitrullinated antibodies (ACPA) positive patients to be predictive …
[HTML][HTML] Dorsal finger fold recognition by convolutional neural networks for the detection and monitoring of joint swelling in patients with rheumatoid arthritis
…, M Caorsi, J Maglione, D Dan, A Dumusc… - Digital …, 2022 - karger.com
Digital biomarkers such as wearables are of increasing interest in monitoring rheumatic
diseases, but they usually lack disease specificity. In this study, we apply convolutional neural …
diseases, but they usually lack disease specificity. In this study, we apply convolutional neural …
[HTML][HTML] A prospective evaluation of ultrasound as a diagnostic tool in acute microcrystalline arthritis
P Zufferey, R Valcov, I Fabreguet, A Dumusc… - Arthritis research & …, 2015 - Springer
Introduction The performance of ultrasound (US) in the diagnosis of acute gouty (MSU) arthritis
and calcium pyrophosphate (CPP) arthritis is not yet well defined. Most studies evaluated …
and calcium pyrophosphate (CPP) arthritis is not yet well defined. Most studies evaluated …
Efficacy of anakinra in acute hydroxyapatite calcification-induced joint pain: a retrospective study of 23 cases
P Zufferey, R Valcov, M Thomas, A Dumusc, M Forien… - Joint Bone Spine, 2019 - Elsevier
Objective Hydroxyapatite (HA) crystal calcifications in or around the joint can induce acute
flares with severe pain. A previous pilot study suggested that the interleukin-1β (IL-1β) …
flares with severe pain. A previous pilot study suggested that the interleukin-1β (IL-1β) …
[HTML][HTML] Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study
A Dumusc, F Alromaih, M Perreau, T Hügle… - Arthritis Research & …, 2023 - Springer
Background In Switzerland, rituximab (RTX) is licenced for the treatment of rheumatoid arthritis
(RA) and ANCA-associated vasculitis (AAV) but is frequently used off-label to treat other …
(RA) and ANCA-associated vasculitis (AAV) but is frequently used off-label to treat other …
Anakinra compared to prednisone in the treatment of acute CPPD crystal arthritis: A randomized controlled double-blinded pilot study.
A Dumusc, C Benaim, P Zufferey, B Aubry-Rozier… - Joint Bone …, 2020 - europepmc.org
A comment on this article appears in" Treatment of acute CPP crystal arthritis: What are we
missing? Comment on:" Anakinra compared to prednisone in the treatment of acute CPPD …
missing? Comment on:" Anakinra compared to prednisone in the treatment of acute CPPD …
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's …
OBJECTIVES: To assess the use of the Clinical EULAR Sjogren's Syndrome Disease Activity
Index (ClinESSDAI), a version of the ESSDAI without the biological domain, for assessing …
Index (ClinESSDAI), a version of the ESSDAI without the biological domain, for assessing …